Betz Stephen F.insider trades
In SEC Form 4 filings, Betz Stephen F. is listed as Chief Scientific Officer of Crinetics Pharmaceuticals, Inc. (CRNX). Betz Stephen F. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 1.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | Chief Scientific Officer | 13 | Sep 1 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-01
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 58,286 | $85.00 | $4,954,310 | 79,650 | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D | 79,650 | $85.00 | $6,770,250 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 90,514 | $83.09 | $7,520,808 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 74,540 | $75.72 | $5,644,169 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 56,250 | $59.81 | $3,364,313 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 60,000 | $62.39 | $3,743,400 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 85,000 | $69.71 | $5,925,350 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 15,000 | $61.81 | $927,150 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 77,000 | $64.98 | $5,003,460 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 110,000 | $65.36 | $7,189,600 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 87,000 | $41.49 | $3,609,630 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 65,000 | $48.14 | $3,129,100 | not reported | No | Form 4 |
| CRNXCrinetics Pharmaceuticals, Inc. | Sep 1 | Sep 1 | D · derivative | 47,000 | $41.21 | $1,936,870 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.